Fainting disorder mechanism figured out

March 24, 2017, Monash University
Fainting disorder mechanism figured out
Fainting caused by POTS is regulated by switching gene function off. Credit: Imgur/Twoisnoe

Monash University researchers have discovered the mechanism underlying the fainting disorder, Postural Orthostatic Tachycardia Syndrome (POTS), the condition famously affecting the former lead singer of The Wiggles.

POTS is a disorder characterised by orthostatic intolerance – having difficulty in becoming upright, particularly when standing up from a lying-down position, when a greatly reduced volume of blood returns to the heart. Symptoms can include feeling light-headed, fainting, fatigue and slurred speech. Interestingly, eighty per cent of those with the condition are women.

Greg Page AM, the "Yellow Wiggle," left the popular children's music group in late 2006 for some years after developing symptoms associated with POTS, later dubbed 'Wiggles Disease'.

Monash Central Clinical School (CCS) investigators Professor Sam El-Osta and then PhD student Abdul Waleed Khan – who joined the CCS from the Baker Heart and Diabetes Institute with the opening of the new Department of Diabetes at Monash – have revealed that the problem has an epigenetic, rather than genetic, basis.

While the gene implicated in POTS – norepinephrine transporter (NET) – was known for several decades, past research had failed to find a genetic mutation responsible for symptoms of POTS.

The CCS scientists discovered chemical marks on the NET gene responsible for repressing or turning the gene off. They delved further and found that a repressor protein called MeCP2 together with a non-coding RNA (let-7i) was critical in the .

In another exciting development, the researchers, collaborating with the Baker Institute's Professor Murray Esler, demonstrated that the NET gene could be re-activated by using the FDA approved drug Vorinostat in blood cells derived from POTS study participants.

"The rationale behind our research into POTS was to understand the regulatory mechanism to piece together some of the key molecules involved in NET gene reactivation," Professor El-Osta said.

"The drug we used in the study targets specific molecules in the cell to restore NET gene function."

POTS is a relatively rare condition but the findings may have far wider application.

"This has important therapeutic implications. We have commenced clinical epigenomics studies to assess the generality of the mechanism and therapeutic potential as it pertains to essential hypertension, panic disorder and depressive illness."

Professor El-Osta is now working with Professor Esler's team, which is recruiting patients for a much larger study to test the broader application of the compounds investigated, and others like it, that may also reactivate the NET gene.

Explore further: Poorly understood postural syndrome blights lives of young well educated women

More information: Abdul Waheed Khan et al. NET silencing by let-7i in postural tachycardia syndrome, JCI Insight (2017). DOI: 10.1172/jci.insight.90183

Related Stories

Poorly understood postural syndrome blights lives of young well educated women

June 16, 2014
A debilitating syndrome that causes an excessively rapid heartbeat on standing up, predominantly affects young well educated women, and blights their lives, because it is so poorly understood and inconsistently treated, reveals ...

Low vitamin B12 linked to postural orthostatic tachycardia

December 23, 2013
(HealthDay)—During adolescence, low vitamin B12 levels are associated with postural orthostatic tachycardia syndrome (POTS), according to a study published online Dec. 23 in Pediatrics.

Scientists uncover possible therapeutic targets for rare autism spectrum disorder

January 30, 2017
Researchers have uncovered 30 genes that could, one day, serve as therapeutic targets to reverse Rett syndrome, a rare neurological disorder that affects only girls and is a severe form of an autism spectrum disorder.

Exercise training program improves outcomes in 'Grinch Syndrome' patients

June 20, 2011
An exercise training program worked better than a commonly used beta blocker, significantly improving — even curing — patients with a debilitating heart syndrome, according to research published in Hypertension: ...

Gene ABL1 implicated in both cancer and a developmental disorder

March 14, 2017
ABL1, a human gene well-known for its association with cancer now has been linked to a developmental disorder. The study, which was carried out by a team of researchers from institutions around the world, including Baylor ...

Many chest X-rays in children are unnecessary

December 3, 2014
Researchers at Mayo Clinic found that some children are receiving chest X-rays that may be unnecessary and offer no clinical benefit to the patient, according to a study presented today at the annual meeting of the Radiological ...

Recommended for you

Progress in genetic testing of embryos stokes fears of designer babies

November 16, 2018
Recent announcements by two biotechnology companies have stoked fears that designer babies could soon be an option for those who can afford to pick and choose which features they want for their offspring. The companies, MyOme ...

Gene editing possible for kidney disease

November 16, 2018
For the first time scientists have identified how to halt kidney disease in a life-limiting genetic condition, which may pave the way for personalised treatment in the future.

DICE: Immune cell atlas goes live

November 15, 2018
Compare any two people's DNA and you will find millions of points where their genetic codes differ. Now, scientists at La Jolla Institute for Immunology (LJI) are sharing a trove of data that will be critical for deciphering ...

Ashkenazi Jewish founder mutation identified for Leigh Syndrome

November 15, 2018
Over 30 years ago, Marsha and Allen Barnett lost their sons to a puzzling childhood disease that relentlessly attacked their nervous systems and sapped their energy. After five-year-old Chuckie died suddenly in 1981, doctors ...

Drug candidate may recover vocal abilities lost to ADNP syndrome

November 15, 2018
Activity-dependent neuroprotective protein syndrome (ADNP syndrome) is a rare genetic condition that causes developmental delays, intellectual disability and autism spectrum disorder symptoms in thousands of children worldwide. ...

The puzzle of a mutated gene lurking behind many Parkinson's cases

November 15, 2018
Genetic mutations affecting a single gene play an outsized role in Parkinson's disease. The mutations are generally responsible for the mass die-off of a set of dopamine-secreting, or dopaminergic, nerve cells in the brain ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.